About
Technology
Issues
FAQ
Search
Profile
Top Authors
Prolific Authors
Top Journals
Main Disciplines
Main Topics
Most Cited Articles
Scientometrics
Avg Impact Factor
★★
Articles
★★★
Articles
Citing Bodies
Top Citing Authors
Top Citing Institutions
Top Citing Schools
Top Citing Journals
Top Citing Disciplines
exaly
›
Schools
›
Department of Urology
›
top-articles
Department of Urology
192
(top 1%)
papers
5.3K
(top 1%)
citations
38
(top 1%)
h
-index
67
(top 1%)
g
-index
208
all documents
5.7K
doc citations
1.4K
citing journals
Top Articles
#
Title
Journal
Year
Citations
1
Magnetic nanoparticle hyperthermia for prostate cancer
International Journal of Hyperthermia
2010
381
2
Adjuvant Radiotherapy Versus Wait-and-See After Radical Prostatectomy: 10-year Follow-up of the ARO 96–02/AUO AP 09/95 Trial
European Urology
2014
354
3
MicroRNA profiling of clear cell renal cell cancer identifies a robust signature to define renal malignancy
Journal of Cellular and Molecular Medicine
2009
217
4
Bladder cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up
Annals of Oncology
2022
211
5
Laparoscopic Radical Prostatectomy
European Urology
2001
193
6
LAPAROSCOPIC RADICAL CYSTECTOMY WITH CONTINENT URINARY DIVERSION (RECTAL SIGMOID POUCH) PERFORMED COMPLETELY INTRACORPOREALLY: THE INITIAL 5 CASES
Journal of Urology
2001
190
7
The tumour-targeting human L19-IL2 immunocytokine: Preclinical safety studies, phase I clinical trial in patients with solid tumours and expansion into patients with advanced renal cell carcinoma
European Journal of Cancer
2010
149
8
In search of suitable reference genes for gene expression studies of human renal cell carcinoma by real-time PCR
BMC Molecular Biology
2007
142
9
Immunohistochemical Validation of PSMA Expression Measured by
68
Ga-PSMA PET/CT in Primary Prostate Cancer
Journal of Nuclear Medicine
2018
120
10
GOLPH2 protein expression as a novel tissue biomarker for prostate cancer: implications for tissue-based diagnostics
British Journal of Cancer
2008
119
11
Genitourinary tuberculosis
Current Opinion in Urology
2001
99
12
Diagnostic sensitivity of serum cystatin for impaired glomerular filtration rate
Pediatric Nephrology
1999
88
13
Integrated microRNA and mRNA Signature Associated with the Transition from the Locally Confined to the Metastasized Clear Cell Renal Cell Carcinoma Exemplified by miR-146-5p
PLoS ONE
2016
88
14
Can Tyrosine Kinase Inhibitors be Discontinued in Patients with Metastatic Renal Cell Carcinoma and a Complete Response to Treatment? A Multicentre, Retrospective Analysis
European Urology
2009
87
15
Identification of microRNAs in blood and urine as tumour markers for the detection of urinary bladder cancer
Oncology Reports
2013
76
16
Laparoscopic radical prostatectomy—an analysis of factors affecting operating time
Urology
2003
72
17
PSA and other tissue kallikreins for prostate cancer detection
European Journal of Cancer
2007
72
18
Pasotuxizumab, a BiTE
®
immune therapy for castration-resistant prostate cancer: Phase I, dose-escalation study findings
Immunotherapy
2021
72
19
Management of Lymphoceles After Renal Transplantation: Laparoscopic Versus Open Drainage
Journal of Urology
2003
71
20
ADAM9 Expression is a Significant and Independent Prognostic Marker of PSA Relapse in Prostate Cancer
European Urology
2008
69
21
Exploring the Complexity of Death-Censored Kidney Allograft Failure
Journal of the American Society of Nephrology: JASN
2021
67
22
Nucleic acid-based biomarkers in body fluids of patients with urologic malignancies
Critical Reviews in Clinical Laboratory Sciences
2014
66
23
Sirolimus delays recovery of rat kidney transplants after ischemia-reperfusion injury
Transplantation
2003
62
24
A Bibliometric Evaluation of Publications in Urological Journals among European Union Countries between 2000–2005
European Urology
2007
62
25
Cooperative Effect of miR-141-3p and miR-145-5p in the Regulation of Targets in Clear Cell Renal Cell Carcinoma
PLoS ONE
2016
61
26
PSA and new biomarkers within multivariate models to improve early detection of prostate cancer
Cancer Letters
2007
58
27
LAPAROSCOPIC LIVE DONOR RIGHT NEPHRECTOMY: A NEW TECHNIQUE WITH PRESERVATION OF VASCULAR LENGTH
Journal of Urology
2002
57
28
Salvage radiotherapy after prostatectomy – What is the best time to treat?
Radiotherapy and Oncology
2012
56
29
The percentage of prostate‐specific antigen (
PSA
) isoform [–2]pro
PSA
and the Prostate Health Index improve the diagnostic accuracy for clinically relevant prostate cancer at initial and repeat biopsy compared with total
PSA
and percentage free
PSA
in men aged ≤65 years
BJU International
2016
55
30
Prostate-specific antigen and other serum and urine markers in prostate cancer
Biochimica Et Biophysica Acta: Reviews on Cancer
2014
54
31
Regularly methylated novel pro‐apoptotic genes associated with recurrence in transitional cell carcinoma of the bladder
International Journal of Cancer
2006
53
32
Fatty acid binding proteins (FABPs) in prostate, bladder and kidney cancer cell lines and the use of IL-FABP as survival predictor in patients with renal cell carcinoma
BMC Cancer
2011
53
33
LAPAROSCOPIC RADICAL CYSTECTOMY WITH CONTINENT URINARY DIVERSION (RECTAL SIGMOID POUCH) PERFORMED COMPLETELY INTRACORPOREALLY:
Journal of Urology
2001
50
34
Expression Parameters of the Polycomb Group Proteins BMI1, SUZ12, RING1 and CBX7 in Urothelial Carcinoma of the Bladder and Their Prognostic Relevance
Tumor Biology
2008
49
35
Treatment of varicocele with reference to age: a retrospective comparison of three minimally invasive procedures
Surgical Endoscopy and Other Interventional Techniques
2007
45
36
Selenoprotein P Status Correlates to Cancer-Specific Mortality in Renal Cancer Patients
PLoS ONE
2012
45
37
Expression Profile of the Polycomb Group Protein Enhancer of Zeste Homologue 2 and its Prognostic Relevance in Renal Cell Carcinoma
Journal of Urology
2009
44
38
Volume matters: CT-based renal cortex volume measurement in the evaluation of living kidney donors
Transplant International
2013
42
39
Phase 3 Study of Adjuvant Radiotherapy Versus Wait and See in pT3 Prostate Cancer: Impact of Pathology Review on Analysis
European Urology
2013
38
40
Quantitative evaluation of telomerase subunits in urine as biomarkers for noninvasive detection of bladder cancer
International Journal of Cancer
2005
36
41
Dose Escalation for Patients with Decreasing PSA during Radiotherapy for Elevated PSA after Radical Prostatectomy Improves Biochemical Progression-Free Survival
Strahlentherapie Und Onkologie
2011
36
42
Response to olaparib in a
PALB2
germline mutated prostate cancer and genetic events associated with resistance
Journal of Physical Education and Sports Management
2019
36
43
Laparoscopic live donor right nephrectomy: a new technique with preservation of vascular length
Transplantation Proceedings
2003
35
44
Positive Margins after Laparoscopic Radical Prostatectomy: A Prospective Study of 100 Cases Performed by 4 Different Surgeons
European Urology
2003
34
45
Male Extragonadal Germ Cell Tumors of the Adult
Oncology Research and Treatment
2016
32
46
Different prostate-specific antigen assays give different results on the same blood sample: an obstacle to recommending uniform limits for prostate biopsies
BJU International
2007
30
47
Impact of obstructive interval and sperm granuloma on patency and pregnancy after vasectomy reversal
Journal of Developmental and Physical Disabilities
2010
29
48
Treatment of everolimus-resistant metastatic renal cell carcinoma with VEGF-targeted therapies
British Journal of Cancer
2011
29
49
Diagnostic performance of PI-RADS version 2.1 compared to version 2.0 for detection of peripheral and transition zone prostate cancer
Scientific Reports
2020
29
50
2021 Updated European Association of Urology Guidelines on the Use of Adjuvant Pembrolizumab for Renal Cell Carcinoma
European Urology
2022
29
site/software ©
exaly
; All materials licenced under
CC by-SA
.